Astrana Health Stock Net Income
| ASTH Stock | 22.00 0.52 2.42% |
As of the 28th of January, Astrana Health shows the Mean Deviation of 3.3, standard deviation of 5.36, and Risk Adjusted Performance of (0.06). Astrana Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Astrana Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.5873 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 57.4 M | 60.3 M | |
| Net Income From Continuing Ops | 57.4 M | 33.1 M | |
| Net Income Applicable To Common Shares | 56.4 M | 59.2 M | |
| Net Income Per Share | 0.81 | 0.86 | |
| Net Income Per E B T | 0.61 | 0.64 |
Astrana | Net Income | Build AI portfolio with Astrana Stock |
Latest Astrana Health's Net Income Growth Pattern
Below is the plot of the Net Income of Astrana Health over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Astrana Health financial statement analysis. It represents the amount of money remaining after all of Astrana Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Astrana Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 49.93 M | 10 Years Trend |
|
Net Income |
| Timeline |
Astrana Net Income Regression Statistics
| Arithmetic Mean | 18,348,117 | |
| Geometric Mean | 9,573,780 | |
| Coefficient Of Variation | 158.99 | |
| Mean Deviation | 25,535,152 | |
| Median | 10,835,002 | |
| Standard Deviation | 29,171,481 | |
| Sample Variance | 851T | |
| Range | 92.7M | |
| R-Value | 0.76 | |
| Mean Square Error | 383.2T | |
| R-Squared | 0.58 | |
| Significance | 0.0004 | |
| Slope | 4,391,432 | |
| Total Sum of Squares | 13615.6T |
Astrana Net Income History
Other Fundumenentals of Astrana Health
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Astrana Health Net Income component correlations
Astrana Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Astrana Health is extremely important. It helps to project a fair market value of Astrana Stock properly, considering its historical fundamentals such as Net Income. Since Astrana Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Astrana Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Astrana Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Astrana Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Astrana Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Astrana Health.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Astrana Health on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Astrana Health or generate 0.0% return on investment in Astrana Health over 90 days. Astrana Health is related to or competes with Select Medical, Mednax, National HealthCare, Aveanna Healthcare, Acadia Healthcare, US Physicalrapy, and MannKind Corp. Astrana Health is entity of United States More
Astrana Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Astrana Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Astrana Health upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 31.71 | |||
| Value At Risk | (7.67) | |||
| Potential Upside | 6.14 |
Astrana Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Astrana Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Astrana Health's standard deviation. In reality, there are many statistical measures that can use Astrana Health historical prices to predict the future Astrana Health's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.18) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astrana Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Astrana Health January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.17) | |||
| Mean Deviation | 3.3 | |||
| Coefficient Of Variation | (1,152) | |||
| Standard Deviation | 5.36 | |||
| Variance | 28.73 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.18) | |||
| Maximum Drawdown | 31.71 | |||
| Value At Risk | (7.67) | |||
| Potential Upside | 6.14 | |||
| Skewness | (2.06) | |||
| Kurtosis | 7.44 |
Astrana Health Backtested Returns
Astrana Health secures Sharpe Ratio (or Efficiency) of -0.079, which signifies that the company had a -0.079 % return per unit of risk over the last 3 months. Astrana Health exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Astrana Health's Standard Deviation of 5.36, risk adjusted performance of (0.06), and Mean Deviation of 3.3 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 2.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Astrana Health will likely underperform. At this point, Astrana Health has a negative expected return of -0.44%. Please make sure to confirm Astrana Health's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Astrana Health performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.58 |
Good reverse predictability
Astrana Health has good reverse predictability. Overlapping area represents the amount of predictability between Astrana Health time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Astrana Health price movement. The serial correlation of -0.58 indicates that roughly 58.0% of current Astrana Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.58 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 4.53 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Astrana Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Astrana Health reported net income of 49.93 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is notably lower than that of the firm.
Astrana Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.Astrana Health is currently under evaluation in net income category among its peers.
Astrana Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Astrana Health from analyzing Astrana Health's financial statements. These drivers represent accounts that assess Astrana Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Astrana Health's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 3.2B | 1.3B | 1.8B | 1.5B | 1.4B | 1.0B | |
| Enterprise Value | 3.2B | 1.3B | 1.8B | 1.7B | 1.5B | 1.1B |
Astrana Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Astrana Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Astrana Health's managers, analysts, and investors.Environmental | Governance | Social |
Astrana Health Institutional Holders
Institutional Holdings refers to the ownership stake in Astrana Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Astrana Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Astrana Health's value.| Shares | Northern Trust Corp | 2025-06-30 | 434.5 K | Jacobs Levy Equity Management, Inc. | 2025-06-30 | 420.1 K | Royal Bank Of Canada | 2025-06-30 | 317.1 K | Royce & Associates, Lp | 2025-06-30 | 307.5 K | Hotchkis & Wiley Capital Management Llc | 2025-06-30 | 292.4 K | Diamond Hill Capital Management Inc | 2025-06-30 | 271.5 K | Bank Of New York Mellon Corp | 2025-06-30 | 251.9 K | Amvescap Plc. | 2025-06-30 | 240.2 K | Principal Financial Group Inc | 2025-06-30 | 222.4 K | Blackrock Inc | 2025-06-30 | 6 M | Vanguard Group Inc | 2025-06-30 | 4.8 M |
Astrana Fundamentals
| Return On Equity | 0.0183 | ||||
| Return On Asset | 0.0288 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.7 B | ||||
| Shares Outstanding | 50.16 M | ||||
| Shares Owned By Insiders | 22.11 % | ||||
| Shares Owned By Institutions | 55.39 % | ||||
| Number Of Shares Shorted | 2.56 M | ||||
| Price To Book | 1.39 X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 2.03 B | ||||
| Gross Profit | 296.97 M | ||||
| EBITDA | 141.84 M | ||||
| Net Income | 49.93 M | ||||
| Total Debt | 471.84 M | ||||
| Book Value Per Share | 15.70 X | ||||
| Cash Flow From Operations | 52.2 M | ||||
| Short Ratio | 4.85 X | ||||
| Earnings Per Share | 0.19 X | ||||
| Target Price | 36.89 | ||||
| Number Of Employees | 1.9 K | ||||
| Beta | 0.87 | ||||
| Market Capitalization | 1.1 B | ||||
| Total Asset | 1.35 B | ||||
| Retained Earnings | 286.28 M | ||||
| Working Capital | 272.89 M | ||||
| Net Asset | 1.35 B |
About Astrana Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:Check out Astrana Health Piotroski F Score and Astrana Health Altman Z Score analysis. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.